Zevra Therapeutics, Inc. (ZVRA) Tops Q2 EPS by 16c, beats revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Wall St futures mixed as Apple falls on margin warning, midterm results awaited
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: ZVRA) | Delayed: 10.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.10 | 52 Week High | $ | |||
| Open | $10.10 | 52 Week Low | $ | |||
| Day High | $10.10 | P/E | N/A | |||
| Day Low | $10.10 | EPS | $ | |||
| Volume | 155,093 | |||||
